The results demonstrate feasibility of utilizing the minimum amount of drug in order to achieve a desired effect. Both 4-factor PCC and rFVIIa appear to be safe and effective options for the management of bleeding associated with cardiac surgery.
This review describes the impact of current developments and new modalities for the surgical and anesthetic management of ruptured descending thoracic aortic aneurysm (rDTAA).
